Early Allograft Dysfunction (EAD) After Liver Transplantation
Structured Summary — Prof. Sanjaya Satapathy, MD, FAASLD
1. Main Clinical Topics Discussed
- Definition and formal diagnostic criteria for Early Allograft Dysfunction (EAD)
- Differentiation of EAD from Ischemia-Reperfusion Injury (IRI) and Primary Non-Function (PNF)
- Risk factors predisposing to EAD
- Prognostic implications and clinical management thresholds
- Role of imaging in evaluation of worsening graft function
2. Key Learning Points, Guidelines, and Recommendations
Formal Definition — Olthoff (UOTS) Criteria
EAD is diagnosed when any one of the following criteria is met:
- AST or ALT > 2,000 IU/L at any point within the first 7 post-operative days
- INR ≥ 1.6 on post-operative day 7
- Total bilirubin ≥ 10 mg/dL on post-operative day 7
> ⚠️ Critical board point: Only one criterion is required. Two of the three criteria are specifically anchored to post-operative day 7.
Criterion-Specific Clarifications
AST/ALT Criterion:
- A single value exceeding 2,000 IU/L at any point in the first 7 days satisfies EAD criteria
- Rapid subsequent decline does not negate the diagnosis
- Reflects ischemia-reperfusion injury magnitude, not necessarily sustained dysfunction
INR Criterion (most prognostically significant):
- Must be ≥ 1.6 specifically on day 7 — not day 1 or day 3
- Reflects impaired synthetic function; persistent coagulopathy at day 7 indicates failure of clotting factor synthesis
- Transient early INR elevation may reflect intraoperative factors and does not qualify
Bilirubin Criterion:
- Must be ≥ 10 mg/dL specifically on day 7
- Reflects impaired excretory function and cholestasis
- Bilirubin of 11 mg/dL on day 3, or 9.8 mg/dL on day 7, does not meet criteria — thresholds are strict
3. Specific Clinical Data, Statistics, and Study Results Cited
- EAD incidence: Occurs in approximately 20–40% of liver transplants, varying by donor and recipient factors
- Associated morbidity: EAD correlates with:
- Longer ICU stays
- Increased transfusion requirements
- Greater need for hemodynamic support
- Higher short-term complication rates and early mortality compared to uncomplicated transplants
- Prognosis: EAD does not equal graft failure; the majority of affected grafts recover with supportive care
- Risk factors identified:
- Donation after Circulatory Death (DCD) grafts — additional warm ischemia exposure
- Graft steatosis — impaired microcirculation and mitochondrial recovery
- Older donor age — reduced regenerative capacity
- Prolonged cold ischemia time — strongest modifiable risk factor
- Intraoperative hypotension — worsens reperfusion injury
4. Practical Takeaways for Clinicians
Diagnostic vigilance:
- Monitor AST/ALT daily in the first 7 days; a single value > 2,000 IU/L qualifies as EAD regardless of trend
- Treat post-operative day 7 as a critical checkpoint — assess INR and bilirubin specifically at this timepoint
- Understand that early enzyme spikes are expected (IRI); it is failure to recover by day 7 that defines EAD
Distinguishing EAD from Primary Non-Function (PNF):
| Feature | EAD | PNF |
|---|
| AST/ALT | Elevated, may improve | Severely elevated, rising |
|